Position in ABBV
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$5,105,775
+$695,078 QoQ
Shares Held
20,290
+0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.42%
of 13F equity value
Holder Rank
#1,295
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Ceeto Capital Group, LLC holds $22,200,435 across 8 Drug Manufacturers - General names. ABBV ranks #1 (23.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
This page
|
20,290 | $5,105,775 | |
| 2 | MRK |
Merck & Co., Inc.
|
29,864 | $3,837,524 | |
| 3 | LLY |
ELI LILLY & Co
|
3,030 | $3,634,273 | |
| 4 | AMGN |
Amgen Inc
|
9,675 | $3,503,511 | |
| 5 | JNJ |
Johnson & Johnson
|
8,418 | $2,137,919 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
33,250 | $1,915,865 | |
| 7 | PFE |
Pfizer Inc
|
53,250 | $1,282,260 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
6,200 | $783,308 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,105,775 | 20,290 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $4,410,697 | 20,280 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $4,448,700 | 19,470 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $4,506,463 | 19,463 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $3,610,680 | 19,452 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $4,000,155 | 19,092 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $3,390,871 | 19,082 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $3,726,842 | 18,872 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $3,543,946 | 20,662 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $3,760,547 | 20,651 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $3,198,580 | 20,640 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $3,074,809 | 20,628 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $2,548,822 | 18,918 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $3,013,049 | 18,906 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $3,053,782 | 18,896 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $2,527,711 | 18,834 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,883,083 | 18,824 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $3,049,937 | 18,814 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $2,613,626 | 19,303 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $2,081,028 | 19,292 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $2,903,859 | 25,780 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $2,788,721 | 25,769 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $2,743,682 | 25,606 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $2,180,991 | 24,900 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $2,136,985 | 21,766 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $1,516,181 | 19,900 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||